Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A by Hirokazu Kashiwagi, Masamichi Shiraga, Hisashi Kato, Tsuyoshi.

Slides:



Advertisements
Similar presentations
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Advertisements

Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34+ cells are.
by Wei Zhang, and Robert W. Colman
by Matilde Murga, Oscar Fernandez-Capetillo, and Giovanna Tosato
Roles of RabGEF1/Rabex-5 domains in regulating FcϵRI surface expression and FcϵRI-dependent responses in mast cells by Janet Kalesnikoff, Eon J. Rios,
Ligand binding to integrin αvβ3requires tyrosine 178 in the αv subunit
Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets by Gerlinde R. Van de Walle, Anne Schoolmeester,
by Matt W. Goschnick, Lai-Man Lau, Janet L. Wee, Yong S. Liu, P
Tissue-Specific Expression of Functional Platelet Factor XI Is Independent of Plasma Factor XI Expression by Chang-jun Hu, Frank A. Baglia, David C.B.
Functional analysis of the cytoplasmic domain of the integrin α1 subunit in endothelial cells by Tristin D. Abair, Nada Bulus, Corina Borza, Munirathinam.
PRT , a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model by Michael P. Reilly, Uma Sinha,
by Rong He, Hairong Sang, and Richard D. Ye
by Koji Nakamura, Alexander Malykhin, and K. Mark Coggeshall
S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation
Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin αIIbβ3 by Cindy L. Yap, Karen.
EphB2 and EphB4 receptors forward signaling promotes SDF-1–induced endothelial cell chemotaxis and branching remodeling by Ombretta Salvucci, Maria de.
Christopher L. Kepley, PhD, Bridget S. Wilson, PhD, Janet M
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
by Mineo Iwata, Lynn Graf, Norihiro Awaya, and Beverly Torok-Storb
Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation by Ton Lisman, Jelle Adelmeijer,
by Jing Huang, David G. Motto, David R. Bundle, and J. Evan Sadler
ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding by Ana Kasirer-Friede, Jian Kang, Bryan.
Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin αIIbβ3) and the platelet-activating.
Regulation of monocyte migration by amphoterin (HMGB1)‏
MafB negatively regulates RANKL-mediated osteoclast differentiation
by Veerendra Munugalavadla, Jovencio Borneo, David A
In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth by Laura Conti, Gabriella Regis, Angela Longo, Paola Bernabei, Roberto.
Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase iPLA2 by Lionel Blanc, Céline Barres,
Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages by Céline Barrès, Lionel Blanc, Pascale Bette-Bobillo,
Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito by Shigeto Yoshida,
by Jörg Hartleib, Nicola Köhler, Richard B. Dickinson, Gursharan S
Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-α: a basis for local.
by Laurent O. Mosnier, Paula Buijtenhuijs, Pauline F. Marx, Joost C. M
A role for the thiol isomerase protein ERP5 in platelet function
A potential role for α-actinin in inside-out αIIbβ3 signaling
Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity by Ju Hyun Cho, Iain P. Fraser, Koichi Fukase, Shoichi.
Integrin-linked kinase associated with integrin activation
by Thomas T. Murooka, Ramtin Rahbar, Leonidas C
by Bruno Bernardi, Gianni F. Guidetti, Francesca Campus, Jill R
Molecular and functional analysis of Shiga toxin–induced response patterns in human vascular endothelial cells by Andreas Matussek, Joerg Lauber, Anna.
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions by Claire Abbal, Martine Lambelet, Debora Bertaggia, Carole.
Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages by Sophia.
Β1 integrin−mediated signals are required for platelet granule secretion and hemostasis in mouse by Tobias Petzold, Raphael Ruppert, Dharmendra Pandey,
Impaired activation of platelets lacking protein kinase C-θ isoform
Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cδ–dependent mechanisms by Man-Gen.
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies by Inés González-García,
by Herbert Bosshart, and Ruth F. Jarrett
Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production in vitro by José Perdomo, Feng Yan,
by Mi-Ae Kang, Su-Young Yun, and Jonghwa Won
Apoptotic Vascular Endothelial Cells Become Procoagulant
by Monika Priwitzerova, Guangjun Nie, Alex D
Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac by Alice Y. Pollitt, Beata Grygielska, Bertrand.
Volume 4, Issue 6, Pages (June 1996)
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival by Diana Starlets, Yael Gore, Inbal Binsky, Michal Haran, Nurit.
by A. C. Azim, K. Barkalow, J. Chou, and J. H. Hartwig
Rapid ubiquitination of Syk following GPVI activation in platelets
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo by Rukhsana.
Human osteoarthritic chondrocytes are impaired in matrix metalloproteinase-13 inhibition by IFN-γ due to reduced IFN-γ receptor levels  R. Ahmad, M. El.
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function by Alfonso Catalano, Paola Caprari, Simona Moretti, Monica.
RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists by Peisong Ma, Shuchi Gupta,
Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation by Alexandra Mazharian, Cedric Ghevaert, Lin Zhang, Steffen Massberg,
Volume 62, Issue 3, Pages (September 2002)
Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production by Soe Soe Htwe, Hidenori Wake, Keyue.
by Silvia Mele, Stephen Devereux, Andrea G
Volume 21, Issue 5, Pages (May 2013)
Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts  A. Graness, I. Cicha, M. Goppelt-Struebe 
ELMO1 deficiency enhances platelet function
Silva H Hanissian, Raif S Geha  Immunity 
by Alyssa J. Moroi, Nicole M. Zwifelhofer, Matthew J. Riese, Debra K
Volume 23, Issue 2, Pages (August 2005)
Presentation transcript:

Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A by Hirokazu Kashiwagi, Masamichi Shiraga, Hisashi Kato, Tsuyoshi Kamae, Naoko Yamamoto, Seiji Tadokoro, Yoshiyuki Kurata, Yoshiaki Tomiyama, and Yuzuru Kanakura Blood Volume 106(3):913-921 August 1, 2005 ©2005 by American Society of Hematology

Detection of Sema3A binding to platelets and expression of Sema3A receptors in platelets. Detection of Sema3A binding to platelets and expression of Sema3A receptors in platelets. (A) Silver stain of purified Sema3A fusion proteins; 0.25 μgof Sema3A/Fc (∼ 125 kDa, lane c) and Sema3A/AP (∼ 150 kDa, lane d) were loaded on a 7.5% SDS-PAGE gel under reducing conditions and silver staining was performed. Sema3A/Fc and Sema3A/AP samples contain BSA as a carrier protein. In lane c, only BSA was loaded. Molecular weight marker was loaded in lane a. (B) Binding of Sema3A/Fc or Sema3A/AP to platelets. Washed platelets (5 × 105) were incubated with Sema3A/Fc or hIgG, followed by incubation with FITC anti–human Fc. Sema3A/Fc binding was detected by flow cytometry, and mean fluorescence intensity (MFI) was plotted in the top panel. Washed platelets (5 × 106) were incubated with Sema3A/AP or AP, and after washing, AP activity was measured using disodium phenylphosphate as a substrate. Change in optical density (ΔOD) was plotted on the bottom panel. Shown are representative results of 3 independent experiments. (C) Inhibition of Sema3A/AP binding by Sema3A/Fc. Washed platelets were first incubated with 125 μg/mL hIgG or Sema3A/Fc. Then, platelets were incubated with 10 μg/mL Sema3A/AP, and AP activity was measured. Shown is mean and SE of relative binding to hIgG-incubated sample of 3 independent experiments. (D) Expression of plexin-A1, -A2, or -A3 in platelets was detected by RT-PCR assay (left). Human umbilical vein endothelial cell (HUVEC) was used as a positive control. Expression of neuropilin-1 in platelets was detected by Western blotting and flow cytometric analysis (right). In Western blotting, neuropilin-1 expression was detected by anti–neuropilin-1 antibody, followed by incubation with HRP anti–mouse IgG. MDA-MB231 was used as a positive control. In flow cytometry, platelets were incubated with mouse monoclonal anti–neuropilin-1 antibody (filled curve) or control antibody (MOPC21; open curve), followed by incubation with Alexa488-conjugated anti–mouse IgG. MWM indicates molecular weight marker. Hirokazu Kashiwagi et al. Blood 2005;106:913-921 ©2005 by American Society of Hematology

Inhibition of αIIbβ3 activation by Sema3A. Inhibition of αIIbβ3 activation by Sema3A. (A) Washed platelets preincubated with the indicated concentrations of Sema3A/Fc (♦ and bold lines) or hIgG (▪ and thin lines) were activated with ADP (5 μM), PAR1-TRAP (15 μM), U46619 (2 μM), convulxin (5 ng/mL), A23187 (2.5 μM), or PMA (200 nM). Activated αIIbβ3 was detected by binding of FITC–PAC-1. Shown are representative results of 3 to 5 independent experiments. (B) Washed platelets were preincubated with Sema3A/AP (♦ and bold lines) or AP (▪ and thin lines) and activated by ADP (5 μM) or thrombin (0.5 U/mL), and then FITC–PAC-1 binding was detected. Shown are representative results of 3 independent experiments. (C) PBS-, hIgG-, or Sema3A/Fc-treated platelets were incubated with or without an αIIbβ3-activating antibody, PT25-2, and PAC1 binding was examined. Shown are representative results of 3 independent experiments. Hirokazu Kashiwagi et al. Blood 2005;106:913-921 ©2005 by American Society of Hematology

Inhibition of platelet aggregation by Sema3A. Inhibition of platelet aggregation by Sema3A. Washed platelets preincubated with 20 μg/mL Sema3A/AP or AP were activated with the indicated concentrations of collagen (left column) or thrombin (right column). Platelet aggregation was monitored using a platelet aggregometer. Arrow indicates the addition of agonists. Shown are representative results of 3 independent experiments. Hirokazu Kashiwagi et al. Blood 2005;106:913-921 ©2005 by American Society of Hematology

Inhibition of agonist-induced granular secretion by Sema3A. Inhibition of agonist-induced granular secretion by Sema3A. Washed platelets were preincubated with the indicated concentrations Sema3A/Fc, and then activated with ADP (5 μM) or thrombin (0.5 U/mL). Granular secretion was assessed by FITC-CD62P and PE-CD63 binding to platelets, and percent binding against hIgG-treated platelets was calculated. Shown are mean ± SE of percent binding of 3 independent experiments. *P < .05; **P < .01. Hirokazu Kashiwagi et al. Blood 2005;106:913-921 ©2005 by American Society of Hematology

Effects of Sema3A on platelet adhesion and spreading. Effects of Sema3A on platelet adhesion and spreading. (A) Washed platelets were incubated with 20 μg/mL Sema3A/Fc (bold line) or hIgG (thin solid line), or PBS (dashed line), and then placed on the various concentrations of immobilized fibrinogen for one hour. After washing with PBS to remove nonadherent platelets, adhered platelets were quantified by acid phosphatase method. Mean and SE of percent adhesion of 3 independent experiments was plotted. *P < .05. (B) Sema3A-treated platelets (ii,iv) or hIgG-treated platelets (i,iii) were placed on fibrinogen-coated (i-ii) or nontreated (iii-iv) glass coverslips. Adhered platelets were stained with TRICT (tetramethylrhodamine-5(and 6)-isothiocyanate)–phalloidin. Images were captured with a CCD camera (DP-70; Olympus) mounted on an Olympus AX-80 fluorescence microscope equipped with a 100 ×/1.30 oil immersion objective lens. Images were acquired with Olympus DP Controller software and processed with Adobe Photoshop Elements 2.0 (Adobe Systems, San Jose, CA). Original magnification × 1000, and bar in panel Bi represents 10 μM. Hirokazu Kashiwagi et al. Blood 2005;106:913-921 ©2005 by American Society of Hematology

Effects of Sema3A on F-actin contents, cofilin phosphorylation, and Rac1 activation. Effects of Sema3A on F-actin contents, cofilin phosphorylation, and Rac1 activation. (A) Sema3A/Fc-(gray bars) or hIgG-treated (black bars) platelets were activated by 30 μM PAR1-TRAP or 0.5 U/mL thrombin at 37°C for 30 seconds without stirring. After fixation, F-actin was stained with bodipy-phallacidin. Specific phallacidin binding was obtained by subtraction of FL1 fluorescence with a 300-fold more excess of unlabeled phallacidin from FL1 fluorescence without unlabeled phallacidin, and fold increase against fluorescence of no agonist sample was calculated. Data represent mean and SE of 3 independent experiments. *P < .05. (B) Sema3A/Fc- or hIgG-treated platelets were activated with 30 μM PAR1-TRAP for the indicated time at 37°C without stirring. Then, cells were lysed and SDS-PAGE was performed. Phospho-cofilin was detected by anti–phospho-cofilin–specific antibody. After stripping, total cofilin was detected by anticofilin antibody. Optical density of the bands was measured by NIH Image software, and relative increase against phospho-cofilin in IgG-treated platelets without thrombin was calculated. Mean and SE of 3 independent experiments was plotted in bottom panel. *P < .05; **P < .01. (C) Sema3A/Fc- or hIgG-treated platelets were activated with 30 μM PAR1-TRAP for the indicated time at 37°C without stirring. GTP-form of Rac1 was precipitated by incubation with GST-PAK1-PBD and glutathione beads. After SDS-PAGE electrophoresis, Rac1 was detected by a Rac1-specific antibody. Total Rac was detected by electrophoresis of total lysates on an SDS-PAGE gel followed by detection with the same antibody. Optical density of the bands was measured by NIH Image software, and relative increase against GTP-Rac in IgG-treated platelets without thrombin was calculated. Sema3A/Fc is indicated by ▪ and bold lines; hIgG, by ♦ and thin lines. Mean and SE of 3 independent experiments was plotted in lower panel. *P < .05. Hirokazu Kashiwagi et al. Blood 2005;106:913-921 ©2005 by American Society of Hematology

Effects of Sema3A on thrombin-induced increase of intracellular Ca2+ concentrations. Effects of Sema3A on thrombin-induced increase of intracellular Ca2+concentrations. Fluo-3–labeled platelets were incubated with 20 μg/mL Sema3A/Fc or hIgG. After the determination for about 10 seconds of baseline fluo-3 fluorescence from the platelet population, cell aspiration into the flow cytometry was briefly paused, and 1:10 volume of 5 U/mL thrombin (Thr) was added. The acquisition was then resumed, and changes in log fluorescence versus time were recorded (top panels). For each plot, rectangular analysis regions were defined over the time axis, and mean fluorescence intensity was calculated. Mean ± SE of 3 independent experiments was plotted in bottom panel. Bold and thin lines represent Sema3A/Fc and hIgG, respectively. Hirokazu Kashiwagi et al. Blood 2005;106:913-921 ©2005 by American Society of Hematology